ICON ROA 2010-2023 | ICLR
Current and historical return on assets (ROA) values for ICON (ICLR) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| ICON ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2023-12-31 | $0.61B | $16.99B | 3.58% |
| 2023-09-30 | $0.51B | $17.03B | 3.00% |
| 2023-06-30 | $0.51B | $17.11B | 2.97% |
| 2023-03-31 | $0.51B | $17.29B | 2.97% |
| 2022-12-31 | $0.51B | $17.19B | 2.95% |
| 2022-09-30 | $0.46B | $17.13B | 2.70% |
| 2022-06-30 | $0.21B | $17.04B | 1.21% |
| 2022-03-31 | $0.17B | $17.16B | 1.20% |
| 2021-12-31 | $0.15B | $17.39B | 1.45% |
| 2021-09-30 | $0.18B | $17.66B | 2.53% |
| 2021-06-30 | $0.36B | $3.58B | 10.74% |
| 2021-03-31 | $0.34B | $3.47B | 10.54% |
| 2020-12-31 | $0.33B | $3.44B | 10.92% |
| 2020-09-30 | $0.33B | $3.07B | 11.34% |
| 2020-06-30 | $0.33B | $2.86B | 11.77% |
| 2020-03-31 | $0.38B | $2.84B | 13.48% |
| 2019-12-31 | $0.37B | $2.91B | 13.63% |
| 2019-09-30 | $0.36B | $2.75B | 13.93% |
| 2019-06-30 | $0.35B | $2.72B | 14.11% |
| 2019-03-31 | $0.33B | $2.61B | 14.08% |
| 2018-12-31 | $0.32B | $2.35B | 14.24% |
| 2018-09-30 | $0.31B | $2.33B | 13.81% |
| 2018-06-30 | $0.30B | $2.17B | 13.73% |
| 2018-03-31 | $0.29B | $2.22B | 13.84% |
| 2017-12-31 | $0.28B | $2.15B | 14.12% |
| 2017-09-30 | $0.28B | $2.05B | 14.87% |
| 2017-06-30 | $0.27B | $1.90B | 14.64% |
| 2017-03-31 | $0.27B | $1.86B | 14.73% |
| 2016-12-31 | $0.26B | $1.83B | 14.41% |
| 2016-09-30 | $0.25B | $1.90B | 14.07% |
| 2016-06-30 | $0.25B | $1.75B | 14.13% |
| 2016-03-31 | $0.25B | $1.80B | 14.25% |
| 2015-12-31 | $0.24B | $1.72B | 14.24% |
| 2015-09-30 | $0.23B | $1.81B | 14.04% |
| 2015-06-30 | $0.22B | $1.64B | 13.81% |
| 2015-03-31 | $0.20B | $1.61B | 12.90% |
| 2014-12-31 | $0.18B | $1.53B | 11.84% |
| 2014-09-30 | $0.16B | $1.57B | 10.62% |
| 2014-06-30 | $0.14B | $1.53B | 9.49% |
| 2014-03-31 | $0.12B | $1.49B | 8.53% |
| 2013-12-31 | $0.10B | $1.44B | 7.66% |
| 2013-09-30 | $0.09B | $1.36B | 7.08% |
| 2013-06-30 | $0.08B | $1.29B | 6.58% |
| 2013-03-31 | $0.07B | $1.23B | 6.08% |
| 2012-12-31 | $0.06B | $1.20B | 5.34% |
| 2012-09-30 | $0.04B | $1.14B | 4.00% |
| 2012-06-30 | $0.02B | $1.11B | 2.13% |
| 2012-03-31 | $0.02B | $1.13B | 2.18% |
| 2011-12-31 | $0.02B | $1.04B | 2.14% |
| 2011-09-30 | $0.04B | $1.05B | 3.98% |
| 2011-06-30 | $0.06B | $1.01B | 6.44% |
| 2011-03-31 | $0.07B | $1.01B | 7.72% |
| 2010-12-31 | $0.09B | $0.95B | 9.49% |
| 2010-09-30 | $0.10B | $0.94B | 10.59% |
| 2010-06-30 | $0.10B | $0.88B | 11.08% |
| 2010-03-31 | $0.10B | $0.90B | 10.60% |
| 2009-12-31 | $0.10B | $0.91B | 10.62% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $23.778B | $8.120B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $123.512B | 15.50 |
| Cencora (COR) | United States | $47.702B | 19.04 |
| DiDi Global (DIDIY) | China | $21.472B | 0.00 |
| Avantor (AVTR) | United States | $16.347B | 22.52 |
| Viatris (VTRS) | United States | $13.496B | 3.85 |
| CochLear (CHEOY) | $13.392B | 0.00 | |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.462B | 0.00 |
| Revvity (RVTY) | United States | $12.459B | 21.69 |
| Charles River Laboratories (CRL) | United States | $11.682B | 21.29 |
| Medpace Holdings (MEDP) | United States | $11.526B | 41.89 |
| Solventum (SOLV) | United States | $10.730B | 0.00 |
| Natera (NTRA) | United States | $10.298B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.940B | 51.85 |
| Bausch + Lomb (BLCO) | Canada | $5.145B | 19.78 |
| Doximity (DOCS) | United States | $4.595B | 34.21 |
| Organon (OGN) | United States | $4.555B | 4.41 |
| PACS (PACS) | United States | $3.551B | 0.00 |
| Progyny (PGNY) | United States | $3.143B | 52.74 |
| Sotera Health (SHC) | United States | $3.100B | 15.21 |
| Surgery Partners (SGRY) | United States | $3.017B | 28.03 |
| Life Times (LTH) | United States | $2.756B | 30.46 |
| GoodRx Holdings (GDRX) | United States | $2.643B | 133.80 |
| Premier (PINC) | United States | $2.538B | 9.29 |
| Agilon Health (AGL) | United States | $2.244B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.198B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.158B | 6.98 |
| BrightSpring Health Services (BTSG) | United States | $1.799B | 0.00 |
| Agiliti (AGTI) | United States | $1.366B | 22.31 |
| Establishment Labs Holdings (ESTA) | $1.301B | 0.00 | |
| NovoCure (NVCR) | Jersey | $1.301B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.983B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.759B | 7.85 |
| Embecta (EMBC) | United States | $0.611B | 4.04 |
| InnovAge Holding (INNV) | United States | $0.537B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.519B | 0.00 |
| Enhabit (EHAB) | United States | $0.514B | 46.59 |
| Auna S.A (AUNA) | Luxembourg | $0.503B | 0.00 |
| CareDx (CDNA) | United States | $0.430B | 0.00 |
| MultiPlan (MPLN) | United States | $0.419B | 0.00 |
| Beauty Health (SKIN) | United States | $0.404B | 0.00 |
| LifeMD (LFMD) | United States | $0.392B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.388B | 0.00 |
| DocGo (DCGO) | United States | $0.372B | 59.50 |
| Sera Prognostics (SERA) | United States | $0.316B | 0.00 |
| ModivCare (MODV) | United States | $0.302B | 4.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.263B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.251B | 0.00 |
| Sharecare (SHCR) | United States | $0.235B | 0.00 |
| Biodesix (BDSX) | United States | $0.121B | 0.00 |
| So-Young (SY) | China | $0.115B | 38.67 |
| Oncology Institute (TOI) | United States | $0.088B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.064B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
| NeueHealth (NEUE) | United States | $0.048B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.029B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| OpGen (OPGN) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |